SUPN

Supernus Pharmaceuticals, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Market|US

Price

$50.48

Market Cap

$2.91B

Beta

0.72

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+8.63%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+2.52%

P/E Ratio0.0

PEG Ratio—

FCF Yield+1.58%

Debt / Equity0.04

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for SUPN.